" " indicates required fields
Risk that's live.
Not last quarter's snapshot.
EVSec continuously recalculates your product risk posture as threats evolve, CVEs land, and architecture changes. No manual rework. No stale data. A remediation engine then prioritizes the fixes that matter most, optimizing for time, cost, and effort.
0
Real-time
Risk models built at design freeze don't reflect OTA updates, new components, or supplier changes.
Teams spend days cross-referencing CVEs against inventories. EVSec does it in seconds.
Engineering, compliance, and leadership see different data. No unified risk posture exists.
Without scenario modeling, teams miss the optimal path balancing effort, cost, and residual risk.
Competitors give you static snapshots
EVSec gives you a living system
UN R155
ISO/SAE 21434
FDA 524B
EU CRA
IEC 62443
NIST SSDF
AIS 189
ISO 14971
GB 44495-2024
ANSI/AAMI SW96:2023
"When a CVE is disclosed, the system manages it. We do not halt innovation."
Tier 1 Automotive Supplier
CRO
C2A Security
VP and GM, Medical Technology
C2A Security
Ken Zalevsky brings over 20 years of medical device cybersecurity experience to his role at C2A Security, where he serves as VP and GM, Medical Technology, following the acquisition of Vigilant Ops in October 2025. A former Bayer executive, Ken founded Vigilant Ops in 2019 after witnessing the consequences of inadequate technical preparation in the healthcare industry. He is an active contributor to CISA’s SBOM working groups and a frequent speaker on software supply chain security. Ken’s mission: transform SBOM from a compliance checkbox into operational intelligence that keeps patients safe while streamlining regulatory processes.